CLOZAPINE N-OXIDE

TargetMol
Product Code: TAR-T4494
Supplier: TargetMol
CodeSizePrice
TAR-T4494-2mg2mg£95.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T4494-5mg5mg£109.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T4494-1mL1 mL * 10 mM (in DMSO)£113.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T4494-10mg10mg£133.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T4494-25mg25mg£172.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T4494-50mg50mg£221.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T4494-100mg100mg£296.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Clozapine N-oxide is a major metabolite of clozapine that can be detected in the earliest excretion time interval after clozapine administration [1]. It is produced by the action of cytochrome P450 (CYP) isoforms CYP1A2 and CYP3A4, whose activities, in turn, can be affected by drugs and disease [2]. Clozapine N-oxide is normally biologically inactive. However, it can be used in designer receptor exclusively activated by designer drugs, also known as DREADDs, technology to modulate synthetic receptors in vivo [3].
CAS:
34233-69-7
Formula:
C18H19ClN4O
Molecular Weight:
342.83
Pathway:
GPCR/G Protein; Neuroscience; Metabolism
Purity:
0.9994
SMILES:
C[N+]1([O-])CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12
Target:
Dopamine Receptor; 5-HT Receptor; AChR; Drug Metabolite

References

Wang Y, Liu N, Ma L, et al.Ventral Hippocampal CA1 Pyramidal Neurons Encode Nociceptive Information.Neuroscience Bulletin.2023: 1-17. Eiermann, B., et al. The involvement of CYP1A2 and CYP3A4 in the metabolism of clozapine. British Journal of Clinical Pharmacology 44(5), 439-446 (1997). Ray, R.S., et al. Impaired respiratory and body temperature control upon acute serotonergic neuron inhibition. Science 333(6042), 637-642 (2012). Ma X, Li L, Li Z, et al. eEF2 in the prefrontal cortex promotes excitatory synaptic transmission and social novelty behavior. EMBO reports. 2022: e54543. Dain, J.G., et al. Biotransformation of clozapine in humans. Drug Metabolism and Disposition 25(5), 603-609 (1997).